In breast cancer, inflammatory blood markers such as C-reactive protein (CRP), neutrophil-to-lymphocyte ratio (NLR), monocyte-to-lymphocyte ratio (MLR), and platelet-to-lymphocyte ratio (PLR) have emerged as important prognostic indicators. This evidence concerns the gene CRP and breast cancer.